MARKET

VRAY

VRAY

ViewRay
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.250
-0.260
-5.77%
After Hours: 4.200 -0.05 -1.18% 17:25 03/03 EST
OPEN
4.460
PREV CLOSE
4.510
HIGH
4.575
LOW
4.240
VOLUME
1.00M
TURNOVER
--
52 WEEK HIGH
7.36
52 WEEK LOW
1.106
MARKET CAP
672.62M
P/E (TTM)
-4.9373
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
A Preview Of ViewRay's Earnings
ViewRay (NASDAQ:VRAY) announces its next round of earnings this Thursday, March 04. Here is Benzinga's look at ViewRay's Q4 earnings report. Net Income, Earnings, And Earnings Per Share Earnings and especially earnings per share (EPS) are useful measures o...
Benzinga · 6h ago
Radiotherapy Market Research Report 2020-2024 By Players, Regions, Product Types And Applications
Mar 03, 2021 (AmericaNewsHour) -- Global Radiotherapy Market AnalysisAccording to Verified Market Research, The Global Radiotherapy Market was valued at USD...
AmericaNewsHour · 13h ago
Radiation Therapy Market Size, Share to Witness Remunerative Growth During 2020-2025 - Industry Analysis
Mar 02, 2021 (Market Insight Reports) -- Selbyville, Delaware. The report Radiation Therapy Market Size and Analysis maintains enhanced dynamics and is...
Market Insight Reports · 1d ago
Global Radiation Oncology Market Forecast To 2027 By Trends and Drivers, Restraints, and Opportunities
Japan, Japan, Tue, 02 Mar 2021 02:44:58 / Comserve Inc. / -- Key Players: Accuray Incorporated, Elekta AB, Varian Medical Systems, C.R. Bard, Inc., IBA...
Comserve · 1d ago
Global Radiation Therapy Market - Analysis By Product Type (External Beam RT, Internal Beam RT), By Application, By End User, By Region, By Country (2020 Edition): Market Insights, Covid-19 Impact, Competition and Forecast (2020-2025)
Feb 26, 2021 (Heraldkeepers) -- Executive Summary The global radiation therapy market was valued at USD 5216.04 million in the year 2019, according to a...
Heraldkeepers · 5d ago
Radiotherapy Market Research Report 2020-2024 By Players, Regions, Product Types And Applications
Feb 23, 2021 (AmericaNewsHour) -- Global Radiotherapy Market AnalysisAccording to Verified Market Research, The Global Radiotherapy Market was valued at USD...
AmericaNewsHour · 02/23 05:16
Global Radiation Therapy Market Delivers Top Companies Analysis, Regions and Applications 2024
Feb 19, 2021 (The Expresswire) -- The global radiation therapy market is expected to reach US$10.11 billion in 2024, witnessing growth at a CAGR of 3.38%,...
The Express Wire · 02/20 03:54
ViewRay Announces Conference Call for Fourth Quarter and Full Year 2020 Financial Results to be Held After Market on March 4, 2021
, /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2020 financial results.
PR Newswire - PRF · 02/19 21:01
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of VRAY. Analyze the recent business situations of ViewRay through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average VRAY stock price target is 5.88 with a high estimate of 8.25 and a low estimate of 3.000.
EPS
Institutional Holdings
Institutions: 225
Institutional Holdings: 173.81M
% Owned: 109.82%
Shares Outstanding: 158.26M
TypeInstitutionsShares
Increased
36
9.30M
New
32
-1.25M
Decreased
30
2.43M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-2.96%
Healthcare Equipment & Supplies
-2.63%
Key Executives
Chairman/Independent Director
Daniel Moore
President/Chief Executive Officer/Director
Scott Drake
Chief Financial Officer
Brian Knaley
Chief Financial Officer
Zachary Stassen
Chief Operating Officer
Shahriar Matin
Chief Scientific Officer
James Dempsey
Director
Phil Spencer
Independent Director
Caley Castelein
Independent Director
Scott Huennekens
Independent Director
B. Kristine Johnson
Independent Director
Brian Roberts
Independent Director
Gail Wilensky
Independent Director
Kevin Xie
Independent Director
Ted Wang
  • Dividends
  • Splits
  • Insider Activity
No Data
About VRAY
ViewRay Inc. designs, manufactures and markets the ViewRay MRIdian. The MRIdian is a system that integrates high quality radiation therapy with simultaneous magnetic resonance imaging (MRI). It provides two generations of the MRIdian: the first generation MRIdian with Cobalt-60 based radiation beams and the second generation MRIdian Linac, with linear accelerator (linac) based radiation beams. The MRIdian combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients. MRIdian also records the level of radiation dose that the treatment area has received. MRIdian system is comprised of three components: the MRI system, the radiation delivery system and an integrated treatment planning and delivery software. The MRI system is the component of MRIdian that captures soft tissue images of the patient’s body. Its MRI system captures and displays live images in one plane, four times per second or in three planes, two times per second.

Webull offers kinds of Viewray Inc stock information, including NASDAQ:VRAY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRAY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VRAY stock methods without spending real money on the virtual paper trading platform.